vimarsana.com

Page 123 - ஸ்டான்போர்ட் பல்கலைக்கழகம் பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The radiation danger to astronauts- cancer, heart disease -an ethical problem

The radiation danger to astronauts- cancer, heart disease -an ethical problem “These are all crucial studies to be conducted in order to really understand the risks we’re exposing astronauts to,” says Meerman. “Therefore, we believe we are not there yet and we should debate whether it is safe to expand human space travel significantly 08 Mar 2021  A team of US and Netherlands-based scientists has published a review paper highlighting ways to protect astronauts from the negative cardiovascular health impacts associated with exposure to space radiation during long-distance space travel. Cardiovascular impacts Space radiation is currently regarded as the most limiting factor for long-distance space travel because exposure to it is associated with significant negative effects on the human body. However, data on these effects are currently only available for those members of the Apollo programme that travelled as far as the Moon – too small a number from which to draw an

Affibody and Inmagene autoimmune partnership completes regulatory milestone

Affibody and Inmagene autoimmune partnership completes regulatory milestone Affibody and Inmagene Biopharmaceuticals report that the US FDA has cleared the interleukin-17 (IL-17) blocker, izokibep, to proceed to phase 2 clinical development in non-infectious intermediate, posterior, and pan-uveitis. Uveitis is an orphan disease with significant unmet medical need. It is an inflammation of the uveal tract but can also include the inflammation of nearby tissues, such as the retina, the optic nerve, and the vitreous humor. It is one of the leading causes of blindness worldwide. Sweden’s Affibody and Inmagene, which has wholly owned subsidiaries in San Diego, Shanghai, and Hangzhou, are jointly developing izokibep, a novel bispecific agent, targeting both subunits of IL-17A as well as albumin, to treat multiple autoimmune diseases.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.